Jeffrey Smith, Managing Director at Alder Biopharmaceuticals, holds 8.89K shares in Zymeworks (Ticker: ZYME), holds 0.00 shares in Alder Biopharmaceuticals (Ticker: ALDR).

See the Hottest Stocks Based on Insider Trading >

Jeffrey Smith
Alder Biopharmaceuticals (ALDR)
Managing Director

Ranked #82,550 out of 100,370 Corporate Insiders

Profitable Transactions

1 out of 2 Profitable Transactions

Average Return

-49.40%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

ZYME

A breakdown of Jeffrey Smith's holdings

See the Top Stocks by Insiders

Insider Roles

Zymeworks
(ZYME)

EVP & Chief Medical Officer

Roles that Jeffrey Smith holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Alder Biopharmaceuticals
(ALDR)

Rating:Informative Sell

Date:May 26, 2015 - May 26, 2016

Return:+26.40%

The most profitable trade made by Jeffrey Smith

See the Latest Stocks Traded by Insiders

Jeffrey Smith's Trading History

ALDR

Alder Biopharmaceuticals

Oct 24, 2019

―

Uninformative Sell

387.04K

$0.00

ZYME

Zymeworks

Jan 06, 2025

EVP & Chief Medical Officer

Uninformative Buy

132.64K

$129.79K

List of latest transactions for each holding click on a transaction to see Jeffrey Smith's performance on stock

See All Insider Trading from Today

Jeffrey Smith insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Smith?

The percentage of profitable transactions made by Jeffrey Smith is 50%.

What is the average return per transaction made by Jeffrey Smith?

The average return per transaction made by Jeffrey Smith is -49.40%.

What stocks does Jeffrey Smith hold?

Jeffrey Smith holds: ALDR, ZYME stocks.

What was Jeffrey Smith’s latest transaction?

Jeffrey Smith latest transaction was an Uninformative Buy of $132.64K.

What was Jeffrey Smith's most profitable transaction?

Jeffrey Smith’s most profitable transaction was an Informative Sell of ALDR stock on May 26, 2015. The return on the trade was 26.40%.

What is Jeffrey Smith's role in Alder Biopharmaceuticals?

Jeffrey Smith's role in Alder Biopharmaceuticals is Managing Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Jeffrey Smith Insider Profile

Jeffrey Smith Alder Biopharmaceuticals (ALDR)Managing Director